The Effect of Cognitive Performance on Physical Performance in Adolescent Basketball Players

June 27, 2023 updated by: NAİME ULUG, Atılım University
The aim of this study is to examine the relationship between physical fitness parameters and cognitive performance levels in basketball players. It has been shown in the literature that exercise has an effect on cognitive factors. However, there is a limited number of studies examining the relationship between physical performance parameters and cognitive performance in basketball players.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

Forty-nine male basketball players aged 14-18 years were included in the study. Vertical jump, agility t, reactive agility, 20 m sprint and Y-shaped balance test were applied to all cases as physical performance tests. Right/left discrimination (Recognise application), two-point discrimination, Stroop Test were applied as cognitive performance tests, and the level of pain threshold was evaluated. In the reactive agility test, reactive response speed was evaluated by using visual stimuli, camera and photocell doors. Pearson correlation analysis was used as statistical analysis method.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
49

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Turkey
      • Ankara, Turkey
        • Atılım University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Professional Basketball Athletes

Description

Inclusion Criteria:

  • Male basketball players between the ages of 14-18,
  • To be a licensed athlete for at least 5 years,
  • Being active in sports and training for the last 1 year,
  • Weekly training intensity is at least 5 hours per week

Exclusion Criteria:

  • Having a history of visual, mental or systemic disease,
  • Having a history of major injury in the medical history,
  • Any complaints of acute or chronic pain/injury

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Reactive Agility
Time Frame: 25 June 2023
For the test, the athletes were positioned in the middle of the distance of 16 feet (4.88 meters), 2 meters in front of the warning screen. A and B funnels were introduced to the athlete. When the test started, the warning screen started counting down from 3; at the end of the count, it gave one of the warnings A or B as a random warning. As soon as the athlete saw the warning, he started the test in the direction of the warning that appeared on the screen. The time elapsed between the appearance of the A or B warning on the screen and the athlete's perception and response (knee flexion) was recorded as "reaction time" by watching the Movavi Video Editor Plus 2022 program. After starting the test, the athlete ran and touched the first funnel he turned to, then came back and touched the other funnel. . He turned back to the funnel he touched first and passed through the photocells, completing the test. The time from start to finish was recorded as "reactive agility score".
25 June 2023
Lower Extremity Strength
Time Frame: 25 June 2023
Microgate Witty Brand vertical jump mat was used to evaluate the vertical jump height. The device consists of 2 parts, a matte and a tablet. For the test, the athlete was asked to jump on the mat as described. When the athlete performed the vertical jump, the jump height was recorded by reading from the tablet screen. Before the test, the athletes were given 2 repetitive vertical jumps for trial purposes.
25 June 2023
Agility
Time Frame: 25 June 2023
Agility T Test was used to evaluate Agility. The T-Test was performed using a standardized version from the previous literature [65]. A 10 × 10 meter course was created for the test. The funnels defining the boundaries of the track were numbered. Athletes were asked to return to the cone alignments according to the order specified for the test.
25 June 2023
Running Speed
Time Frame: 25 June 2023
The 20-meter sprint test was used to evaluate the running speed. A 20-meter track was prepared for the test. Athletes were asked to run the 20-meter distance as fast as possible. The fastest time to complete the track was recorded as a score in seconds. Microgate Witty brand photocells were placed at the start and end points to measure the time [66, 67]. The device consists of 3 parts, 2 photocell doors and tablet Photocell doors were positioned on both sides of the start and finish lines. For the test, the athlete started the photocell counter as soon as the athlete crossed the starting line. The finish photocell stopped the counter as soon as the athlete crossed the finish line.
25 June 2023
Balance
Time Frame: 25 June 2023
Y-Shaped Balance Test was used to evaluate upper extremity balance.
25 June 2023
Right/Left Separation
Time Frame: 25 June 2023
Android-based Noi Recognise App application was used for the right-left separation of the athletes. Before the test, the practice was shown to the athletes and a trial test was performed. The test was performed with a mobile device while the athletes were in a sitting position. 20 different images of hands photographed from different angles, used as standard for the test, were shown 5 seconds apart. The athlete was asked to mark which side extremity the picture he saw belonged to as quickly and accurately as possible on the screen of the application. Recognition rates and response speed obtained as a result of the test were recorded as scores on the application.
25 June 2023
Stroop Test
Time Frame: 25 June 2023
The Stroop test is widely used to evaluate cognitive functions such as selective attention and resistance to interference. There are different variations of the Stroop test. In our study, we used the Stroop Test Anchor Form, the validity and reliability of which was made by Savaş et al.
25 June 2023
Two-Point Discrimination
Time Frame: 25 June 2023
Baseline 2-point discrimination instrument was used for the two-point discrimination test. The discrimination tool was set to 5 millimeters. The tips of the instrument were touched to the most swollen area of the hypothenar region of the dominant hand, parallel to the long axis of the hand, and they were asked to say how many points they felt.
25 June 2023
Pain Threshold Level
Time Frame: 25 June 2023
Jtech Commander (JTech Medical Industries, ZEVEX Company) brand algometer device was used to evaluate the pain threshold. The most swollen point of the thenar region of the dominant hand was used to assess the pain threshold.
25 June 2023

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Atılım University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
June 30, 2023

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
July 20, 2023

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
July 20, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
May 24, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 6, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 15, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 28, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 27, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • E-59394181-604.01.02-32301

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings